[go: up one dir, main page]

GB0206217D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0206217D0
GB0206217D0 GB0206217A GB0206217A GB0206217D0 GB 0206217 D0 GB0206217 D0 GB 0206217D0 GB 0206217 A GB0206217 A GB 0206217A GB 0206217 A GB0206217 A GB 0206217A GB 0206217 D0 GB0206217 D0 GB 0206217D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0206217A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0206217A priority Critical patent/GB0206217D0/en
Publication of GB0206217D0 publication Critical patent/GB0206217D0/en
Priority to EP03727265A priority patent/EP1487424B1/en
Priority to SI200330576T priority patent/SI1487424T1/en
Priority to US10/507,642 priority patent/US20050124624A1/en
Priority to AU2003233946A priority patent/AU2003233946A1/en
Priority to DK03727265T priority patent/DK1487424T3/en
Priority to PCT/EP2003/002709 priority patent/WO2003077892A2/en
Priority to AT03727265T priority patent/ATE339197T1/en
Priority to ES03727265T priority patent/ES2274234T3/en
Priority to PT03727265T priority patent/PT1487424E/en
Priority to DE60308337T priority patent/DE60308337T2/en
Priority to JP2003575945A priority patent/JP2005527523A/en
Priority to CY20061101774T priority patent/CY1105839T1/en
Ceased legal-status Critical Current

Links

GB0206217A 2002-03-15 2002-03-15 Organic compounds Ceased GB0206217D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB0206217A GB0206217D0 (en) 2002-03-15 2002-03-15 Organic compounds
JP2003575945A JP2005527523A (en) 2002-03-15 2003-03-14 4- (4-Methylpiperazin-1-ylmethyl) -N- [4-methyl-3- (4-pyridin-3-yl) pyrimidin-2-yl-amino] phenyl] for treating AngII-mediated diseases -Benzamide
PCT/EP2003/002709 WO2003077892A2 (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for treating ang ii-mediated diseases
SI200330576T SI1487424T1 (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
US10/507,642 US20050124624A1 (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases
AU2003233946A AU2003233946A1 (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
DK03727265T DK1487424T3 (en) 2002-03-15 2003-03-14 4- (4-Methylpiperazin-1-ylmethyl) -N- (4-methyl-3- (4-pyridin-3-yl) -pyrimidin-2-yl-amino) phenyl-benzamide for the treatment of Ang II-mediated diseases
EP03727265A EP1487424B1 (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
AT03727265T ATE339197T1 (en) 2002-03-15 2003-03-14 4-(4-METHYLPIPERAZINE-1-YLMETHYL)-N-(4-METHYL-3- 4-PYRIMINDINE-3-YL)PYRIMIDINE-2-YL-AMINO)PHENYL)-BENZAMIDE FOR THE TREATMENT OF ANG-II MEDIATED DISEASES
ES03727265T ES2274234T3 (en) 2002-03-15 2003-03-14 4- (4-METHYLPIPERAZIN-1-ILMETIL) -N- (4-METHYL-3 (4-PIRIDIN-3-IL) PIRIMIDIN -2-ILAMINO) PHENYL) -BENZAMIDE FOR THE TREATMENT OF DISEASES MEDIATED BY ANG II.
PT03727265T PT1487424E (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
DE60308337T DE60308337T2 (en) 2002-03-15 2003-03-14 4- (4-Methylpiperazin-1-ylmethyl) -N- (4-methyl-3- (4-pyrimidin-3-yl) pyrimidin-2-ylamino) phenylbenzamide for the treatment of Ang II mediated disorders
CY20061101774T CY1105839T1 (en) 2002-03-15 2006-12-11 4-(4-METHYLPIPEPAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YL-AMINO)PHENYL]-BENZAMIDE FOR THE TREATMENT OF ANG II - MEDIATED DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0206217A GB0206217D0 (en) 2002-03-15 2002-03-15 Organic compounds

Publications (1)

Publication Number Publication Date
GB0206217D0 true GB0206217D0 (en) 2002-05-01

Family

ID=9933094

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0206217A Ceased GB0206217D0 (en) 2002-03-15 2002-03-15 Organic compounds

Country Status (1)

Country Link
GB (1) GB0206217D0 (en)

Similar Documents

Publication Publication Date Title
GB0203276D0 (en) Organic compounds
GB0202873D0 (en) Organic compounds
GB0209265D0 (en) Organic compounds
GB0205281D0 (en) Organic compounds
GB0200429D0 (en) Organic compounds
EG23462A (en) Organic compounds
GB0209481D0 (en) Organic compounds
GB0203061D0 (en) Organic compounds
GB0204756D0 (en) Organic compounds
GB0202874D0 (en) Organic compounds
GB0209257D0 (en) Organic compounds
GB0205023D0 (en) Organic compounds
GB0206366D0 (en) Organic compounds
GB0202381D0 (en) Organic compounds
GB0202875D0 (en) Organic compounds
GB0201913D0 (en) Organic compounds
GB0203189D0 (en) Organic compounds
GB0201881D0 (en) Organic compounds
GB0204752D0 (en) Organic compounds
GB0204754D0 (en) Organic compounds
GB0201610D0 (en) Organic compounds
GB0204763D0 (en) Organic compounds
GB0204765D0 (en) Organic compounds
GB0204766D0 (en) Organic compounds
GB0206217D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)